159 related articles for article (PubMed ID: 2847420)
1. Herpes simplex virus latent infection: reactivation and elimination of latency after neurectomy.
Tenser RB; Edris WA; Hay KA
Virology; 1988 Nov; 167(1):302-5. PubMed ID: 2847420
[TBL] [Abstract][Full Text] [Related]
2. Neuronal control of herpes simplex virus latency.
Tenser RB; Edris WA; Hay KA
Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
[TBL] [Abstract][Full Text] [Related]
3. Reactivation in vivo and in vitro of herpes simplex virus from mouse dorsal root ganglia which contain different levels of latency-associated transcripts.
Ecob-Prince MS; Rixon FJ; Preston CM; Hassan K; Kennedy PG
J Gen Virol; 1993 Jun; 74 ( Pt 6)():995-1002. PubMed ID: 8389814
[TBL] [Abstract][Full Text] [Related]
4. Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy.
Walz MA; Price RW; Notkins AL
Science; 1974 Jun; 184(4142):1185-7. PubMed ID: 4364361
[TBL] [Abstract][Full Text] [Related]
5. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
Field HJ; Lay E
Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
[TBL] [Abstract][Full Text] [Related]
6. Dissemination of herpes simplex virus in ganglia after footpad inoculation in neurectomized and non-neurectomized mice.
Klein RJ; DeStefano E
Arch Virol; 1983; 77(2-4):231-8. PubMed ID: 6314936
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
Al-Saadi SA; Gross P; Wildy P
J Gen Virol; 1988 Feb; 69 ( Pt 2)():433-8. PubMed ID: 2828517
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
Liu WG; Chen ZJ; Song JZ; Ma ZX
Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus latency in the nervous system--a new model.
Steiner I; Kennedy PG
Neuropathol Appl Neurobiol; 1991 Dec; 17(6):433-40. PubMed ID: 1666173
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 2 establishes latency in the mouse footpad and in the sensory ganglia.
Subak-Sharpe JH; Al-Saadi SA; Clements GB
J Invest Dermatol; 1984 Jul; 83(1 Suppl):67s-71s. PubMed ID: 6330225
[TBL] [Abstract][Full Text] [Related]
11. Stress-induced reactivation of latent herpes simplex virus infection in rat lumbar dorsal root ganglia.
Blondeau JM; Aoki FY; Glavin GB
J Psychosom Res; 1993 Dec; 37(8):843-9. PubMed ID: 8301624
[TBL] [Abstract][Full Text] [Related]
12. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus latency: the cellular location of virus in dorsal root ganglia and the fate of the infected cell following virus activation.
McLennan JL; Darby G
J Gen Virol; 1980 Dec; 51(Pt 2):233-43. PubMed ID: 6262435
[TBL] [Abstract][Full Text] [Related]
14. Visualization of replicating herpes simplex virus in cervical dorsal root ganglia of mice following explant of individual ganglion onto susceptible indicator cells.
Blondeau JM; Embil JA; McFarlane ES; James H; Henry M; Sangalang VE
J Med Virol; 1986 Dec; 20(4):341-6. PubMed ID: 3025352
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
Klein RJ
Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
[TBL] [Abstract][Full Text] [Related]
16. Apparent stability of herpes simplex virus genomes isolated from primary and recurrent infections and dorsal root ganglia in the mouse.
Blondeau JM; Embil JA; McFarlane ES
J Med Microbiol; 1988 Dec; 27(4):291-6. PubMed ID: 2848947
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the in vitro-reactivation of latent herpes simplex virus infection in spinal ganglia: comparison of various immune factors. Brief report.
von Rheinbaben F; Schneweis KE
Arch Virol; 1986; 87(3-4):315-9. PubMed ID: 2418807
[TBL] [Abstract][Full Text] [Related]
18. Enhanced in vitro reactivation of herpes simplex virus type 2 from latently infected guinea-pig neural tissues by 5-azacytidine.
Stephanopoulos DE; Kappes JC; Bernstein DI
J Gen Virol; 1988 May; 69 ( Pt 5)():1079-83. PubMed ID: 2453606
[TBL] [Abstract][Full Text] [Related]
19. Biological and molecular aspects on herpes simplex virus latency.
Lycke E
Scand J Infect Dis Suppl; 1990; 69():113-9. PubMed ID: 2175937
[TBL] [Abstract][Full Text] [Related]
20. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency.
MacLean A; Robertson L; McKay E; Brown SM
J Gen Virol; 1991 Sep; 72 ( Pt 9)():2305-10. PubMed ID: 1654382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
